A Mark Fendrick MD
Professor, Internal Medicine, University of Michigan Medical School
Join to View Full Profile
1500 E Medical Center Dr# 3Ann Arbor, MI 48109
Phone+1 734-936-5582
Dr. Fendrick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemResidency, Internal Medicine, 1987 - 1990
Harvard Medical SchoolClass of 1987
Certifications & Licensure
MI State Medical License 1993 - 2027
PA State Medical License 1988 - 1994
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Multicancer Early Detection Tests at a Crossroads: Commercial Availability Ahead of Definitive Evidence.Carmen E Guerra, Jennifer Keating Litton, Carolina E Viswanath, A Mark Fendrick
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2025-06-01 - Brand-to-brand nonmedical switching among interleukin-17 inhibitors or other biologics: Implications of a formulary change.A Mark Fendrick, Manish Mittal, Yi Peng, Beverly Johns, Cynthia Holmes
Journal of Managed Care & Specialty Pharmacy. 2025-04-23 - Fiscal Impact of Expanded Medicare Coverage for GLP-1 Receptor Agonists to Treat Obesity.Jennifer H Hwang, Neda Laiteerapong, Elbert S Huang, Dariush Mozaffarian, A Mark Fendrick
JAMA Health Forum. 2025-04-04
Journal Articles
- The Need to Expand Coverage and Enhance Access to Essential Services on a Predeductible Basis Following COVID-19A Fendrick, MD, JAMA Network Open
Press Mentions
Brand-to-Brand Nonmedical Switching Among Interleukin-17 Inhibitors or Other Biologics: Implications of a Formulary ChangeApril 23rd, 2025- Telemedicine Hands Out Green Dividend, Emerges as a Prescription Beyond Exam RoomsApril 22nd, 2025
- R.I.P. VBID. Is Medicare Advantage Alone or Will It Go Beyond?February 27th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
